These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 4547404)

  • 21. Model for exchange kinetics of aprindine in man after single and multiple doses.
    Delcroix C; Martin L; Van Durme JP; Kesteloot H; Hagemeijer F; Mbuyamba P; Deblecker M
    Acta Cardiol; 1974; Suppl 18():177-94. PubMed ID: 4547521
    [No Abstract]   [Full Text] [Related]  

  • 22. Treatment of chronic ventricular dysrhythmias with a new drug: aprindine (AC 1802).
    Van Durme JP; Rousseau M; Mbuyamba P
    Acta Cardiol; 1974; Suppl 18():335-40. PubMed ID: 4138863
    [No Abstract]   [Full Text] [Related]  

  • 23. [Clinical experiences with a new orally effective antiarrhythmic agent (Aprindin)].
    Breithardt G; Gleichmann U; Seipel L; Loogen F
    Z Kardiol; 1974 May; 63(3):435-44. PubMed ID: 4608660
    [No Abstract]   [Full Text] [Related]  

  • 24. [Clinical study of a new anti-arrhythmia agent: aprindine].
    Palma-Gamiz JL; Boedo C; Lopez-Pujol FJ; de Uria JS
    Acta Cardiol; 1974; Suppl 18():361-8. PubMed ID: 4138640
    [No Abstract]   [Full Text] [Related]  

  • 25. Preliminary experience in the treatment of cardiac arrhythmias with aprindine.
    Bollen G; Enderle J
    Acta Cardiol; 1974; Suppl 18():355-60. PubMed ID: 4138528
    [No Abstract]   [Full Text] [Related]  

  • 26. Rate rhythm and voltage dependent effects of aprindine: a test of a model of the mechanisms of action of antiarrhythmic drugs.
    Moyer JW; Hondeghem LM
    Proc West Pharmacol Soc; 1978; 21():57-61. PubMed ID: 693540
    [No Abstract]   [Full Text] [Related]  

  • 27. [Effects of aprindine on the electromechanical coupling of the myocardium and smooth muscle].
    Cargnelli G; Finotti P; Gobbato S; Padrini R
    Boll Soc Ital Biol Sper; 1980 Mar; 56(5):474-80. PubMed ID: 7387791
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of rhythm disorders with aprindine. Results in 86 patients].
    Besse P; Giraudel JL; Grosgogeat Y; Haiat R; Puech P; Saulnier JP
    Acta Cardiol; 1974; Suppl 18():389-407. PubMed ID: 4138152
    [No Abstract]   [Full Text] [Related]  

  • 29. Long-term oral antiarrhythmic therapy with aprindine (AC 1802).
    Breithardt G; Gleichmann U; Seipel L; Loogen F
    Acta Cardiol; 1974; Suppl 18():341-53. PubMed ID: 4138089
    [No Abstract]   [Full Text] [Related]  

  • 30. Therapeutic effectiveness and plasma levels of aprindine, a new antidysrhythmic drug.
    Van Durme JP; Bogaert MG; Rosseel MT
    Eur J Clin Pharmacol; 1974 Aug; 7(5):343-6. PubMed ID: 4607575
    [No Abstract]   [Full Text] [Related]  

  • 31. [Action of anti-arrhythmia agents on intracardiac conduction].
    Kulbertus H; Collignon P
    Acta Cardiol; 1974; Suppl 18():241-50. PubMed ID: 4547514
    [No Abstract]   [Full Text] [Related]  

  • 32. [Pharmacokinetic characteristics and biodegradation of aprindin in man].
    Dodion L; de Suray JM; Deblecker M; Georges A
    Therapie; 1974; 29(2):221-32. PubMed ID: 4849380
    [No Abstract]   [Full Text] [Related]  

  • 33. Effects of encainide on myocardial contractility of cat papillary muscle.
    Brutsaert DL
    Eur J Pharmacol; 1981 Dec; 76(2-3):267-9. PubMed ID: 6800830
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Oral antiarrhythmic longtime therapy with aprindine (AC 1802)].
    Breithardt G; Gleichmann U; Seipel L
    Verh Dtsch Ges Inn Med; 1973; 79():1001-3. PubMed ID: 4790079
    [No Abstract]   [Full Text] [Related]  

  • 35. Action of antiarrhythmic drugs on His bundle electrogram and sinus node function.
    Seipel L; Both A; Breithardt G; Gleichmann U; Loogen F
    Acta Cardiol; 1974; Suppl 18():251-67. PubMed ID: 4547552
    [No Abstract]   [Full Text] [Related]  

  • 36. Changes of refractory periods in the A-V conduction system induced by antiarrhythmic drugs. A study using His bundle recordings.
    Schlepper M; Neuss H
    Acta Cardiol; 1974; Suppl 18():269-77. PubMed ID: 4547475
    [No Abstract]   [Full Text] [Related]  

  • 37. Pharmacological evaluation of aprindine (AC 1802) a new antiarrhythmic agent.
    Georges A; Hosslet A; Duvernay G
    Acta Cardiol; 1973; 28(2):166-91. PubMed ID: 4540792
    [No Abstract]   [Full Text] [Related]  

  • 38. Comparative myocardial depressant and anti-arrhythmic properties of d-propranolol, dl-propranolol and quinidine.
    Parmley WW; Braunwald E
    J Pharmacol Exp Ther; 1967 Oct; 158(1):11-21. PubMed ID: 6054071
    [No Abstract]   [Full Text] [Related]  

  • 39. [Effects of changrolin on contractility and excitability of isolated cat papillary muscle].
    Li RS; Chen WZ; Zhang YF; Ding GS
    Zhongguo Yao Li Xue Bao; 1984 Mar; 5(1):26-9. PubMed ID: 6232815
    [No Abstract]   [Full Text] [Related]  

  • 40. Cardiovascular effects of aprindine, a new antiarrhythmic drug.
    Remme WJ; Verdouw PD
    Eur J Cardiol; 1975 Dec; 3(4):307-13. PubMed ID: 1193115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.